Figure 2
Figure 2. Genotype and expression of human CCL3L1. (A) The top plot shows the standard curves with the slope and the square of the Pearson correlation coefficient (R2). The bottom plot shows the amplification curves obtained using 6 (1:2) serial dilutions in triplicate, ranging from 25 to 1.56 ng human genomic DNA extracted from the cell line A431 that contains 2 copies of CCL3L1 per diploid genome. The plots were obtained using Chromo4 Continuous Fluorescence Detector System. (B) Distribution of median CCL3L1 copy numbers in HIV-1 LTNPs, HTLV-2/HIV-1 LTNPs, and HTLV-2/HIV-1MEU subjects; P values indicate significance by the Wilcoxon test. (C) Differential CCL3L1 gene expression levels (expressed as mean of fold changes) in cellular extracts of PHA-activated PBMCs of control seronegative persons and of unstimulated PBMCs from infected persons.

Genotype and expression of human CCL3L1. (A) The top plot shows the standard curves with the slope and the square of the Pearson correlation coefficient (R2). The bottom plot shows the amplification curves obtained using 6 (1:2) serial dilutions in triplicate, ranging from 25 to 1.56 ng human genomic DNA extracted from the cell line A431 that contains 2 copies of CCL3L1 per diploid genome. The plots were obtained using Chromo4 Continuous Fluorescence Detector System. (B) Distribution of median CCL3L1 copy numbers in HIV-1 LTNPs, HTLV-2/HIV-1 LTNPs, and HTLV-2/HIV-1MEU subjects; P values indicate significance by the Wilcoxon test. (C) Differential CCL3L1 gene expression levels (expressed as mean of fold changes) in cellular extracts of PHA-activated PBMCs of control seronegative persons and of unstimulated PBMCs from infected persons.

Close Modal

or Create an Account

Close Modal
Close Modal